(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD)...
Stats | |
---|---|
Dagens volum | 1.79M |
Gjennomsnittsvolum | 1.22M |
Markedsverdi | 9.56B |
EPS | $-0.860 ( 2023-08-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -56.47 |
ATR14 | $2.40 (1.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-16 | Hendrix Martin | Sell | 2 071 | Common Stock |
2023-06-16 | Hendrix Martin | Sell | 40 000 | Stock Option (right to buy) |
2023-06-16 | Hendrix Martin | Sell | 20 500 | Stock Option (right to buy) |
2023-06-16 | Laur James | Sell | 2 071 | Common Stock |
2023-06-16 | Laur James | Sell | 40 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
-86.78 |
Last 100 transactions |
Buy: 394 552 | Sell: 5 154 734 |
Volum Korrelasjon
Prometheus Biosciences, Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
KDNY | 0.976 |
KRYS | 0.968 |
AVEO | 0.965 |
ITRI | 0.96 |
BSQR | 0.956 |
PPC | 0.953 |
BLU | 0.952 |
BWMX | 0.951 |
XLRN | 0.951 |
PCTI | 0.951 |
10 Mest negative korrelasjoner | |
---|---|
SMSI | -0.971 |
HLXA | -0.95 |
TWKS | -0.946 |
UPLD | -0.946 |
PEAR | -0.938 |
VORB | -0.935 |
LUNG | -0.933 |
THTX | -0.933 |
ENPH | -0.932 |
XFOR | -0.931 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Prometheus Biosciences, Korrelasjon - Valuta/Råvare
Prometheus Biosciences, Økonomi
Annual | 2023 |
Omsetning: | $6.81M |
Bruttogevinst: | $6.81M (100.00 %) |
EPS: | $-3.49 |
FY | 2023 |
Omsetning: | $6.81M |
Bruttogevinst: | $6.81M (100.00 %) |
EPS: | $-3.49 |
FY | 2022 |
Omsetning: | $3.13M |
Bruttogevinst: | $3.13M (100.00 %) |
EPS: | $-2.87 |
FY | 2020 |
Omsetning: | $1.23M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.376 |
Financial Reports:
No articles found.
Prometheus Biosciences,
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated interstitial lung disease. The company also develops PR600, an anti-tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule for IBD; PR1100, an anti-cytokine receptor mAb for IBD and other immune-mediated diseases; PR1800, an anti-chemokine mAb for IBD; and PR2100, an anti-inflammatory cytokine mAb for IBD. It has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. The company was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. Prometheus Biosciences, Inc. was incorporated in 2016 and is headquartered in San Diego, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.